New York, March 23, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Laser BPH Devices Market Size, Share & Industry Trends ...
Mysuru: Benign Prostatic Hyperplasia (BPH), or prostate enlargement, is a common issue among elderly men in India, often leading to urinary problems like weak or interrupted urine flow, retention, and ...
Data demonstrate that treatment for Benign Prostatic Hyperplasia (BPH) with GreenLight XPS laser therapy with MoXy fiber, instead of transurethral resection of the prostate (TURP), results in ...
Have you been diagnosed with benign prostatic hyperplasia (BPH)? Are you looking for treatment options? If so, HoLEP (Holmium Laser Enucleation of the Prostate) surgery may be the solution for you.
Laser Prostatectomy for BPH On the Rise From 2001-2009, the procedure replaced nearly 50% of transurethral resections of the prostate. Laser prostatectomy use has increased substantially as a ...
DUBLIN--(BUSINESS WIRE)--The "BPH Treatment Device Market Size, Share & COVID-19 Impact Analysis | Global | 2022-2028 | MedCore" report has been added to ResearchAndMarkets.com's offering. The total ...
NICE is supporting use of Boston Scientific's laser therapy GreenLight XPS to treat benign prostatic hyperplasia, which could improve outcomes for patients and save the NHS a substantial chunk of cash ...
BILLERICA, Mass.--(BUSINESS WIRE)--OmniGuide Holdings (OGH) Today, the U.S. Food and Drug Administration cleared RevoLix™ HTL a family of pulsed and continuous wave Thulium YAG lasers is the ...
BPH is the fifth most prevalent non-cancer disorder among men 50 years and older (Rev Urol. 2006;8 [Suppl 3]:S9-S15). Office visits for BPH increased from 10,116 per 100,000 patients in 1994 to 14,473 ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する